Results for tag: "Emerging Infections"

The Emerging Infections market within the context of Infectious Disease Testing is a rapidly growing sector of the healthcare industry. It focuses on the detection and diagnosis of new and emerging infectious diseases, such as those caused by bacteria, viruses, fungi, and parasites. This market is driven by the need to identify and respond to new and emerging infectious diseases, as well as the increasing prevalence of antibiotic-resistant bacteria. The Emerging Infections market includes a variety of diagnostic tests, such as molecular tests, serological tests, and antigen tests. These tests are used to detect and diagnose a wide range of infectious diseases, including those caused by bacteria, viruses, fungi, and parasites. The Emerging Infections market is also supported by the development of new technologies, such as next-generation sequencing and point-of-care testing. These technologies enable rapid and accurate diagnosis of infectious diseases, which is essential for effective treatment and prevention. Some companies in the Emerging Infections market include Cepheid, BioMérieux, Hologic, and Roche Diagnostics. Show Less Read more